Home Tags Cord Blood

Tag: Cord Blood

StemCyte Receives IND Clearance Of Mononuclear Stem Cells In Spinal Cord Injury Clinical Trials

On December 14, 2018, the U.S. Food and Drug Administration (FDA), approved StemCyte’s Phase II Investigational New Drug (IND) application for Allogeneic Human Leukocyte Antigen (HLA)-Matched Umbilical Cord Blood Mononuclear Stem Cells (UCBMNC) (MC001) for the treatment of spinal cord injury. Founded in 1997,...

Phase I/II Study Of Gamida Cell’s NiCord® Universal Bone Marrow Transplant Solution Published

Gamida Cell Ltd., a leading cellular and immune therapeutics company, has announced the publication of data from a multi-center Phase 1/2 clinical study evaluating the safety and efficacy of NiCord® as a stand-alone, hematopoietic stem cell (bone marrow) transplant...

Magenta Therapeutics Presented Cord Blood Derived MGTA-456 Cell Therapy At ASH

Magenta Therapeutics, a clinical-stage biotechnology company presented initial Phase 2 clinical data and preclinical research on its cord blood derived MGTA-456 program at the 60th annual meeting of the American Society of Hematology (ASH) this December in San Diego,...

ExCellThera Presented ECT-001 Enhanced Cord Blood Transplant For Patients With Blood Cancers At ASH

ExCellThera Inc., presented data on the company’s Phase I/II clinical trial using its lead technology, ECT-001, for allogeneic stem cell transplant at the 60th American Society of Hematology (ASH) Meeting, this December in San Diego, USA. Founded in 2015, headquartered...

FDA Clearance For Cesca Therapeutics’ Automated Cord Blood Stem Cell Collection Solution

Cesca Therapeutics Inc., has announced that its device subsidiary, ThermoGenesis® Corp., has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its proprietary AXP® II AutoXpress® Platform (AXP II) for clinical blood banking. Cesca Therapeutics Inc., founded...

GenCure Texas Cord Blood Bank Collects, Tests And Stores Donations

The Texas Cord Blood Bank (TCBB), a program of GenCure, is one of 13 public cord blood banks in the USA and the official cord blood bank of the state of Texas. GenCure, launched in 2010, a subsidiary of BioBridge...

Cellenkos Cleared By FDA To Start Phase I Trials Of Allogeneic Cord Blood-Derived Regulatory...

The United States Food and Drug Administration (FDA) has recently cleared the Investigational New Drug (IND) application of Cellenkos, Inc. The company can now proceed with a phase I clinical trial of its IND first-in-class CK0801, allogeneic cord blood-derived...

California Cryobank Stem Cell Services LLC Has Acquired Cord Blood America Inc

California Cryobank Stem Cell Services LLC ("FamilyCord"), has recently acquired Cord Blood America Inc. ("CBAI"), joining two of the industry's most respected stem cell companies. FamilyCord will maintain the long-term cryogenic storage of the stem cell units in its...

⭐ Recently Featured

🔥 Popular Posts

X